Arizona Sued Pharmacy Managers Over Opioid Crisis
The state alleges pharmacy benefit managers inflated opioid access and risks for Arizona residents.
Updated on Oct. 1, 2026 in Substance Abuse
Live Poll
Do you trust that pharmacy benefit managers prioritize patient health over their own corporate profits?
The Arizona Attorney General has filed a consumer fraud lawsuit against Express Scripts and Optum, accusing the pharmacy benefit managers of fueling the opioid crisis. The litigation claims these companies prioritized profit over patient safety through undisclosed rebate deals and the removal of critical prescribing safeguards.
Why it matters
This lawsuit addresses systemic failures in drug oversight, alleging that the companies bypassed essential safety protocols to prioritize financial gain. It highlights how corporate policies can influence the prevalence and risk profiles of high-stakes medications like OxyContin.
The state's lawsuit is based on an official legal complaint filed by the Arizona Attorney General against Express Scripts and Optum. The filing documents alleged practices such as bypassing step therapy and prior authorization, with the scope of the harm still under legal review.
The players
Arizona Attorney General
The state's primary legal office responsible for protecting consumers and enforcing regulations.
Express Scripts
A pharmacy benefit manager that handles prescription drug plans and mail-order pharmacy operations.
Optum
A pharmacy benefit manager and health services organization involved in drug plan administration.
Purdue Pharma
A pharmaceutical manufacturer known for its production of OxyContin and other opioid products.
The details
Pharmacy benefit managers act as intermediaries between drug manufacturers and insurers, controlling which medications are covered and how easily they are prescribed. The lawsuit claims these companies leveraged their position to secure rebate deals with opioid manufacturers, essentially giving drugs like OxyContin preferred formulary status. Furthermore, they allegedly used real-time prescription data to influence prescribing habits while actively downplaying addiction risks in their communications.
Timeline
September 24, 2026: The Arizona Attorney General announced the lawsuit filing.
Health Landscape
This lawsuit follows the pattern established by the national opioid litigation settlement series by targeting supply chain intermediaries. It highlights the growing scrutiny on how pharmacy benefit managers shape medication access and clinical outcomes on a population scale.
This development serves as a reminder to proactively discuss opioid safety protocols and potential alternatives with your physician if pain management is required. You may also want to verify whether your current health plan uses transparent prior authorization processes for any prescribed medications.
The takeaway
This case underscores the importance of transparency in how pharmacy benefit managers handle high-risk drug coverage. Patients are encouraged to ask their healthcare providers about the safety measures in place for any prescribed opioid treatment to ensure the most evidence-based care.
Further reading
For additional context on the regulation of high-risk medications, visit the Substance Abuse section.
Live Poll
Do you trust that pharmacy benefit managers prioritize patient health over their own corporate profits?
